Microparticles' procoagulant activity and sCD40L concentration during pregnancy in healthy women and women with antiphospholipid syndrome

被引：0
|
作者：
Celinska-Lowenhoff, M. [1 ]
Iwaniec, T. [1 ]
Grzyb, A. [2 ]
Musial, J. [1 ]
机构：
[1] Jagiellonian Univ Med Coll, Dept Med, Krakow, Poland
[2] Jagiellonian Univ Med Coll, Inst Obstet & Gynaecol, Krakow, Poland
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-TH-381
引用
收藏
页码：1059 / 1059
页数：1
相关论文
共 25 条
  • [1] Thrombin activatable fibrinolysis inhibitor antigen and microparticles' procoagulant activity during pregnancy in healthy women and women with autoimmune diseases
    Celinska-Lowenhoff, M.
    Iwaniec, T.
    Wojtowicz, A.
    Pulka, M.
    Musial, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 628 - 628
  • [2] Are the serum levels of sCD40L modified by raloxifene in postmenopausal women?
    Oviedo, Pilar J.
    Hermenegildo, Carlos
    Novella, Susana
    Tarin, Juan J.
    Cano, Antonio
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2008, 140 (02) : 296 - 297
  • [3] CIRCULATING PROCOAGULANT CELL-DERIVED MICROPARTICLES IN WOMEN WITH RECURRENT MISCARRIAGE ASSOCIATED WITH THE ANTIPHOSPHOLIPID SYNDROME
    Tassies, D.
    Martin, L.
    Martinez-Zamora, M. A.
    Garcia, E.
    Monteagudo, J.
    Creus, M.
    Carmona, F.
    Balasch, J.
    Reverter, J. C.
    THROMBOSIS RESEARCH, 2014, 133 : S27 - S27
  • [4] Management and outcomes of women with antiphospholipid syndrome during pregnancy
    Jacqueline J. Tao
    Sanjana Adurty
    Debra D’Angelo
    Maria T. DeSancho
    Journal of Thrombosis and Thrombolysis, 2023, 55 : 751 - 759
  • [5] Management and outcomes of women with antiphospholipid syndrome during pregnancy
    Tao, Jacqueline J. J.
    Adurty, Sanjana
    D'Angelo, Debra
    DeSancho, Maria T. T.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 55 (04) : 751 - 759
  • [6] Management and Outcomes of Women with Antiphospholipid Antibodies or Antiphospholipid Syndrome during Pregnancy
    Tao, Jacqueline J.
    Adurty, Sanjana
    Desancho, Maria T.
    BLOOD, 2021, 138
  • [7] Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy
    Botet, F
    Romera, G
    Montagut, P
    Figueras, J
    Carmona, F
    Balasch, J
    JOURNAL OF PERINATAL MEDICINE, 1997, 25 (02) : 192 - 196
  • [8] Therapeutic dosages of oral or transdermal estradiol did not modify sCD40L levels in postmenopausal women
    Oviedo, Pilar J.
    Hermenegildo, Carlos
    Sobrino, Agua
    Tarin, Juan J.
    Cano, Antonio
    GYNECOLOGICAL ENDOCRINOLOGY, 2008, 24 (06) : 354 - 357
  • [9] sCD40L Is Increased and Associated with the Risk of Gestational Diabetes Mellitus in Pregnant Women with Isolated TPOAb Positivity
    Chen, Xinxin
    Wang, Qingyao
    Cong, Xiangguo
    Jiang, Shuyi
    Li, Shuxiang
    Shen, Qiong
    Chen, Lei
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2022, 2022
  • [10] Acute suppression of circulating sCD40L during hyperglycemia and euglycemic-hyperinsulinemia in healthy young males
    Oliver, Stacy R.
    Flores, Rebecca L.
    Pontello, Andria M.
    Rosa, Jaime S.
    Zaldivar, Frank P.
    Galassetti, Pietro R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (07) : 902 - 910
123